United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 7, 2015
CHINA JO-JO DRUGSTORES, INC.
(Exact name of Registrant as specified in charter)
Nevada | 001-34711 | 98-0557852 | ||
(State or other jurisdiction of Incorporation) |
(Commission File No.) | (IRS Employer Identification No.) |
1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road
Hangzhou, Zhejiang Province, People’s Republic of China
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: +86 (571) 88077078
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item 4.01. Changes in Registrant’s Certifying Accountant.
On April 7, 2015, China Jo-Jo Drugstores, Inc., a corporation incorporated under the laws of the State of Nevada (the “Company”) dismissed Friedman LLP (“Friedman”) as the Company’s independent registered public accounting firm. The decision to dismiss Friedman was approved by the Company’s audit committee.
The principal accountant’s reports of Friedman on the financial statements of the Company as of and for the fiscal years ended March 31, 2014 and 2013 did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles.
During the Company’s two most recent fiscal years and the subsequent interim period through April 7, 2015, there were no disagreements with Friedman on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s) if not resolved to Friedman satisfaction would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report. During the Company’s two most recent fiscal years and the subsequent interim period through April 7, 2015, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K.
The Company provided Friedman with a copy of the foregoing disclosure and requested Friedman to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made therein. A copy of such letter, dated April 7, 2015, furnished by Friedman is filed as Exhibit 16.1 to this Form 8-K.
On April 7, 2015, the Company’s audit committee approved the engagement of BDO China Shu Lun Pan Certified Public Accountants LLP (“BDO China”) as the Company’s new independent registered public accounting firm.
During the Company’s two most recent fiscal years and the subsequent interim period through April 7, 2015, neither the Company nor anyone on its behalf consulted with BDO China regarding (i) the application of accounting principles to a specified transaction, either completed or proposed; the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided that BDO China concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and its related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
16.1 | Letter from Friedman LLP dated April 7, 2015 |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 9, 2015
CHINA JO-JO DRUGSTORES, INC. | ||
By: | /s/ Lei Liu | |
Name: | Lei Liu | |
Title: | Chief Executive Officer |
3